The relevance of the use of psychotropic drugs in clinical oncology
- Авторлар: Zubkova Y.N.1, Kurmukov I.A1, Obukhova O.A1, Kashia S.R1
-
Мекемелер:
- N.N. Blokhin National Medical Research Center of Oncology
- Шығарылым: № 12 (2018)
- Беттер: 14-20
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/295789
- DOI: https://doi.org/10.18565/pharmateca.2018.12.14-20
- ID: 295789
Дәйексөз келтіру
Аннотация
Толық мәтін
Авторлар туралы
Yuliya Zubkova
N.N. Blokhin National Medical Research Center of Oncology
Email: Москва. Россия;e-mail: kostenay@mail.ru
Psychiatrist, Department of Functional Diagnostics, Intensive Care and Rehabilitation
I. Kurmukov
N.N. Blokhin National Medical Research Center of OncologyDepartment of Functional Diagnostics, Intensive Care and Rehabilitation
O. Obukhova
N.N. Blokhin National Medical Research Center of OncologyDepartment of Functional Diagnostics, Intensive Care and Rehabilitation
Sh. Kashia
N.N. Blokhin National Medical Research Center of OncologyDepartment of Functional Diagnostics, Intensive Care and Rehabilitation
Әдебиет тізімі
- Henry G.W. Some modern aspects of psychiatry in general hospital practice. Am. J. Psychiatry 1929;86:481-99
- Lipowski Z.J. Consultation-liaison psychiatry at century's end. Psychosomatics. 1992;33:128-33. doi: 10.1176/ajp.131.6.623
- Patterson K.R. Psycho-Oncology. In: Psychosomatic medicine. K.D. Ackerman, A.F. DiMartini (ed.). Oxford; New York: Oxford University Press, 2015
- Смулевич А.Б. Психосоматические расстройства в онкологии. Эффективная фармакотерапия. 2009;18:28-9. [Smulevich A.B. Psychosomatic disorders in oncology Effektivnaya farmakoterapiya. 2009;18:28-9. (In Russ.)].
- Sutherland A.M. Psychological impact of cancer and its therapy. Med. Clin. North Am. 1956;40(3):705-20.
- Plumb M., Holland J. Comparative studies of psychological function in patients with advanced cancer -I Self-reported depressive symptoms. Psychosom. Med. 1977;39:264-76.
- Maguire G.P., Lee E.G., Bevington D.J., et. al. Psychiatric problems in the first year after mastectomy. Br. Med. J. 1978;15(1):963-65.
- Plumb M., Holland J. Comparative studies of psychological function in patients with advanced cancer II. Interviewer-rated current and past psychological symptoms. Psychosom. Med. 1981;43:243-54.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III). Washington, D.C.: American Psychiatric Publishing, 1980. 494 p.
- Derogatis L.R., Morrow G.R., Fetting J., et al. The prevalence of psychiatric disorders among cancer patient. JAMA. 1983;249(6):751-57.
- Hardman A., Maguire P., Crowther D. The recognition of psychiatric morbidity on a medical oncology ward. J. Psychosom. Res. 1989;33:235-39.
- Razavi D., Delvaux N., Farvacques C., Robaye E. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br. J. Psychiatry. 1990;156:79-83.
- Grassi L., Rosti G., Lasalvia A., Marangolo M. Psychosocial variables associated with mental adjustment to cancer. Psycho-Oncology. 1993;2:11-20.
- Grassi L., Gritti P., Rigatelli M., Gala C. Psychosocial problems secondary to cancer: an Italian multicenter survey of consultation-liason psychiatry in oncology. Eur. J. Cancer. 2000;36:579-85.
- Kissane D.W., Grabsch B., Love A., et al. Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust. N. Z. J. Psychiatry. 2004;38:320-6. PMID: 9734576.
- Prieto J.M., Blanch J., Atala J., et al. C. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J. Clin. Oncol. 2002;20:1907-17.
- Singer S., Szalai C., Briest S., et al. Co-morbid mental health conditions in cancer patients at working age - prevalence, risk profiles, and care uptake. Psychooncology. 2013;22(10):2291-97. doi: 10.1002/pon.3282.
- Singer S., Das- Munshi J., Brachler E. Prevalence of mental health conditions in cancer patients in acute care-a meta-analysis. Ann. Oncol. 2010;21:925 30. doi: 10.1093/annonc/mdp515
- Mitchell A.J., Chan M., Bhatti H., et al. Prevalence of depression, anxiety, and adjustment disorders in oncological, hematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet. Oncol. 2011;12:160-74.
- Miovic M., Block S. Psychiatric disorders in advanced cancer. Cancer. 2007;110:1665-76. doi: 10.1002/cncr.22980.
- Смулевич А.Б., Андрющенко А.В., Бескова Д.А. Психические расстройства в онкологии (результаты мультицентровой программы «Синтез»). Психические расстройства в общей медицине. 2009;1:4-12.
- Derogatis L.R., Feldstein M., Morrow G., et al. A survey of psychotropic drug prescriptions in an oncology population. Cancer. 1979;44:1919-29.
- Jaeger H., Morrow G.R., Carpenter P.J., Brescia F. A survey of psychotropic drug utilization by patients with advanced neoplastic disease. Gen Hosp. Psyciatry. 1985;7:353-60.
- Stiefel F.C., Kornblith A.B., Holland J.C. Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period. Cancer. 1990;65:1048-53.
- Thekdi S.M., Irarrazaval M.E., Dunn L. Psychopharmacological interventions. In: Grassi L., Riba M., editors. Clinical psycho-oncology:an international perspective. Chichester: Wiley, 2012. P. 109-26.
- Caruso R., Grassi L., Nanni M.G., Riba M. Psychopharmacology in psycho-oncology. Curr. Psychiatry Rep. 2013;15(9):393. Doi:10.1007/ s11920-013-0393-0.
- Farriols C., Ferrandez O., Planas J., et al. Changes in the prescription of psychotropic drugs in the palliative care of advanced cancer patients over a seven-year period. J. Pain Sympton. Manage. 2012;43:945-52. Doi: 10.1016/j. jpainsymman.2011.05.010.
- Desplenter F., Bond C., Watson M., et al. Incidence and drug treatment of emotional distress after cancer diagnosis: a matched primary care case-control study. Br. J. Cancer. 2012;107:1644-51. doi: 10.1038/bjc.2012.364.
- De Bock G.H., Musters R.F., Bos H.J., et al. Psychotropoc medication during endocrine treatment for breast cancer. Support Care Cancer. 2012;20:1533-40. doi: 10.1007/s00520-011- 1242-5.
- Ng C.G., Boks M.P., Smeets H.M., et al. Prescription patterns for psychotripic drugs in cancer patients; a large population study in the Netherlands. Psychology. 2013;22:762-67. Doi: 10.1002/ pon.3056.
- Lindqvist O., Lundquist G., Dickman A., et al. Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion. J. Palliative Med. 2013;16:38 43. doi: 10.1089/jpm.2012.0205
- Deyell R.J., Lorenzi M., Ma S., et al. Antidepressant use among survives of childhood, adolescent and young adult cancer: a report of the Childhood, Adolescent and Young Adult Cancer Survivor (CAYACS) Research Program. Pediatr. Blood Canc. 2013;60:816-22.
- Breitbart W., Alici Y. Evidence-based treatment of delirium in patients with cancer. J. Clin. Oncol. 2012;30:1206-14. Doi:10.1200/ JCO.2011.39.8784.
- Rodin G., Lloyd N., Katz M., et al. The treatment of depression in cancer patients: a systematic review. Support Care Cancer. 2007;15(2):123-36.
- Okamura M., Akizuki N., Nakano T., et al. Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer. Psychology. 2008;17(2):154-60.
- Rayner L., Price A., Evans A., et al. Antidepressants for treatment of depression in palliative care: systematic review and metaanalysis. Palliat. Med. 2011;25(1):36-51. doi: 10.1177/0269216310380764.
- Rayner L., Price A., Hotopf M., Higginson I.J. The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur. J. Cancer. 2011;47(5):702-12. Doi:10.1016/j. ejca.2010.11.027.
- Cowan J.D., Palmer T.W. Practical guide to palliative sedation. Curr. Oncol. Rep. 2002;4(3):242-49.
- Kehl K.A. Treatment of terminal restlessness: a review of the evidence. J. Pain Palliative Care Pharmacother. 2004;18(1):5-30.
- Grassi L., Caruso R., Hammelef K., et al. Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review. Int. Rev. Psychiatry 2014;26(1):44-62. doi: 10.3109/09540261.2013.842542.
- Ouwens M., Hulscher M., Hermens R., et al. Implementation of integrated care for patients with cancer: a systematic review of interventions and effects. Int. J. Qual Health Care. 2009;21(2):137 44. doi: 10.1093/intqhc/mzn061
- Ripamonti C., Santini D., Maranzano E., et al. Management of cancer pain: ESMO clinical practice guidelines. Ann. Oncol. 2012;23(7):139-54.
- Bennett M.I. Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review. Palliat. Med. 2011;25:553. doi: 10.1177/0269216310378546.
- Bordeleau L., Pritchard K., Goodwin P., Loprinzi C. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-basedreview. Clin. Therapeut. J. 2007;29(2):230-41. doi: 10.1016/j.clinthera.2007.02.006.
- Kast R.E., Foley K. Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects. Eur. J. Cancer Care (Engl). 2007;16:351-54. doi: 10.1111/j.1365-2354.2006.00760.x.
- Riechelmann R.P., Burman D., Tannock I.F., et al. Phase II trial of mirtazapine for cancer-related cachexia and anorexia. Am. J. Hosp. Pallat. Care. 2012;27:106-10. doi: 10.1177/1049909109345685.
- Breitbart W., Alici-Evcimen Y. Update on psychotropic medications for cancer-related fatigue. J. Natl. Compr. Canc. Netw. 2007;5:1081-91.
- Minton O., Richardson A., Sharpe M., et al. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J. Natl. Cancer Inst. 2008;100:1155-66. doi: 10.1093/jnci/djn250.
- Breitbart W., Alici Y. Psychostimulants for cancer-related fatigue. J. Natl. Compr. Canc. Netw. 2010;8:933-42.
- Minton O., Richardson A., Sharpe M., et al. Psychostimulants for the management of cancer-related fatigue: a systematic review and metaanalysis. J. Pain Symptom Manage. 2011;41:761-67. doi: 10.1016/j.jpainsymman.2010.06.020.
- Bennett M.I., Laird B., Van Litsenburg C., Nimour M. Pregabalin for management of neuropathic pain in adults with cancer: a systematic review of the literature. Pain Med. 2013;5:132-36. doi: 10.1111/pme.12212.